Neuros Medical Inc. has added a medical device industry veteran to its board of directors.
Scott Drees joins the board as an independent director, according to a statement from Neuros. The Willoughby, Ohio company is developing a neurostimulation device that uses a pacemaker-sized generator and an electrode to stimulate nerves to block pain from amputations, sometimes called stump pain, without the use of drugs.
Drees has held executive positions at Johnson & Johnson, Boston Scientific and St. Jude Medical.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Earlier in the summer, Neuros received a $1.5 million grant from the U.S. Department of Defense to speed development of its neurostimulation device. The device is based on technology created by Kevin Kilgore and Dr. Niloy Bhadra of Case Western Reserve University’s Biomedical Engineering Department and MetroHealth Medical Center, both in Cleveland.
